About the Founder 

Mark Spyvee, DPhil. Founder and CEO of RexChem Research

A medicinal chemist, scientific leader and entrepreneur who has consistently generated value for R&D pipelines. Track record includes contributing to the design of 17 innovative compounds for development including 1 approved antifungal agent, 2 anticancer compounds currently progressing through Phase 2 clinical trials and another about to enter Phase 1. Co-author of 65 publications including 36 patent applications. Areas of impact include oncology, immunology, neuroscience, rare genetic disorders, fungicides and insecticides. Interested in opportunities to help create needed pharmaceutical products, especially for PKD, autism and fibrotic diseases. Publications listed at https://scholar.google.com/citations?user=If3hVxoAAAAJ&hl=en